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Healthcare acquired infections (HAIs) cause substantial morbidity and mortality. Copper appears to 48 
have strong antimicrobial properties under laboratory conditions.  49 
Aim  50 
We conducted a systematic review to examine the potential effect of copper treating of commonly 51 
touched surfaces in healthcare facilities.  52 
Methods  53 
We included controlled trials comparing the effect of copper-treated surfaces (furniture or bed 54 
linens) in hospital rooms versus standard rooms on hospital acquired infections (HAIs). Two 55 
reviewers independently screened retrieved articles, extracted data, and assessed the risk of bias of 56 
included studies. The primary outcome was the occurrence of healthcare acquired infections.  57 
Findings 58 
We screened 638 records; 7 studies comprising 12362 patients were included. From risk of bias 59 
assessment, all included studies were judged to be at high risk in ≥2 of the 7 domains of bias. All 7 60 
included studies reported the effect of various copper-treated surfaces on HAIs. Overall, we found 61 
low quality evidence of a potential clinical importance that copper-treated hard surfaces and/or bed 62 
linens and clothes reduced healthcare acquired infections by 27% (RR 0.73; 95% CI 0.57 to 0.94; I2 = 63 
44%, p-value = 0.01).  64 
Conclusion 65 
Given the clinical and economic costs of healthcare acquired infections, the potentially protective 66 
effect of copper-treated surfaces appears important. However, the current evidence is insufficient to 67 
make a strong positive recommendation. However, it would appear worthwhile and urgent to 68 
conduct larger scale publicly funded clinical trials of the impact of copper coating. 69 
70 
Keywords hospital acquired infections, healthcare acquired infection, healthcare associated 71 




Healthcare acquired infections (HAIs) are infections acquired directly or indirectly by patients while 75 
receiving healthcare. HAIs are a major cause of preventable harms, result in substantial morbidity, 76 
prolong hospitalisation, increase the cost of healthcare delivery, and contribute to mortality1,2. 77 
Despite current efforts aiming to prevent and control HAIs, recent estimates suggest that HAIS are 78 
still one of the most prevalent and preventable challenge to patient safety worldwide3,4. 79 
80 
One strategy to control HAIS is to reduce the fomite pathogen transmission that can occur if 81 
common objects such as door handles, stair banisters, table surfaces, utensils or taps are 82 
contaminated5. Cleaning shared surfaces is one proposed preventive mechanism but would require 83 
frequent and extensive cleaning. 84 
85 
Copper appears to have strong bactericidal and viricidal properties and substantially reduces the 86 
duration of pathogen viability on surfaces from days to 30 to 60 minutes under laboratory 87 
conditions6. The inactivation property of copper has been demonstrated for both Norovirus and for 88 
Coronavirus species with inactivation occurring in less than 60 minutes6. Inactivation also occurs on 89 
copper alloys and the activity appears directly proportional to the percentage of copper present in 90 
the alloy. This property has led researchers to examine the potential for copperplating of common 91 
surfaces to reduce healthcare acquired infections with multi-resistant bacteria as well as viruses with 92 
attempts to copperplate common shared surfaces in hospital wards7.  These include surfaces such as 93 
bedrails, door handles, table surfaces, as well as soft textiles such as bed linen, patient gowns and 94 
towels. 95 
96 
If coating of commonly touched surfaces in hospital rooms could reduce healthcare acquired 97 
infections, the impact could be substantial in both health and economic terms8. Therefore, we aimed 98 
to examine the potential of copper coating of common shared surfaces in hospitals. We aimed to 99 
find all controlled trials which had compared copper-treated surfaces in hospital rooms or items with 100 




We aimed to find, appraise, and synthesize eligible studies that have compared the effect of copper-105 
treated hospital room surfaces versus standard room surfaces on healthcare acquired infections. 106 
This systematic review is reported following the Preferred Reporting Items for Systematic Reviews 107 
and Meta-Analyses (PRISMA) statement and the review protocol was prospectively developed9.  108 
Eligibility criteria  109 
Participants. We included studies of patients of any age and with any condition in acute and long-110 
term care settings (including intensive care units, rehabilitation centres, and aged-care facilities). 111 
Interventions. We included studies that evaluated interventions involving copper (or copper alloy) 112 
surfaced rooms or objects in patient care rooms/spaces. We expanded the intervention to include 113 
studies evaluated copper-treated soft textiles such as bed linens, clothes, and gowns as sufficient 114 
data was available.  115 
4 
Comparators. We included studies with any comparator, as long as it did not involve the use of 116 
copper or copper alloy surfaces.  117 
Outcomes (primary, secondary). The primary outcome was the incidence of healthcare acquired 118 
infection (e.g. bacterial or viral infections – not colonisations) in patients. The secondary outcomes 119 
were the incidence of deaths and any skin reactions in patients, and any healthcare acquired 120 
infection (e.g. bacterial or viral) in hospital staff and visitors. We excluded studies that only reported 121 
the rate of colonisations (not infections). 122 
Study design. We included randomised and pseudo-randomised (e.g. alternate allocation) controlled 123 
trials.  124 
Search strategies to identify studies 125 
Database search strings 126 
We searched PubMed, Cochrane CENTRAL and Embase from inception until 25 March 2020. We 127 
designed a search string in PubMed that included the following concepts: Copper AND infections 128 
AND healthcare facility AND controlled trial. The PubMed search string was translated using the 129 
Polyglot Search Translator10 and run in the other two databases (Appendix 1) 130 
Restriction on publication type 131 
No restrictions by language or publication date were imposed. We included publications that were 132 
published in full; publications available as abstract only (e.g. conference abstract) were included if 133 
they had a clinical trial registry record, or other public report, with the additional information 134 
required for inclusion. We excluded publications available as abstract only (e.g. conference abstract) 135 
with no additional information available.  136 
Other searches 137 
On 26 March 2020 we conducted a backwards (cited) and forwards (citing) citation analysis in 138 
Scopus on the included studies identified by the database searches. These were screened against the 139 
inclusion criteria. Clinical trial registries were searched on 25 March 2020 via Cochrane CENTRAL, 140 
which includes the WHO ICTRP and clinicaltrials.gov. 141 
Study selection and screening  142 
Two authors (LA, OB) independently screened the titles and abstracts for inclusion against the 143 
inclusion criteria. One author (JC) retrieved full-texts, and two authors (LA, OB) screened the full-144 
texts for inclusion. Any disagreements were resolved by discussion, or reference to a third author 145 
(PG). The selection process was recorded in sufficient detail to complete a PRISMA flow diagram (see 146 
Figure 1) and a list of excluded full-text articles with reasons for exclusions (see Appendix 2).   147 
Data extraction  148 
We used a data extraction form for study characteristics and outcome data, which was piloted on 149 
two studies in the review. Two authors (LA, OB) extracted the following data from included studies: 150 
1. Methods: study authors, location, study design, duration of study, duration of follow-up151 
2. Participants: N, age (mean or median; range), gender, diagnosis or infection type at admission,152 
ward or room type admitted to (e.g. intensive care, acute care, long-term care)153 
3. Interventions and comparators: type of copper coating (e.g. copper percentage in the alloy),154 
type of surfaces covered by copper/copper alloy (e.g. bed controls, tables, etc.), type of155 
comparator, average duration of stay in the room.156 
4. Outcomes: primary and secondary outcomes: incidence of healthcare acquired infections (e.g.157 
bacterial or viral infections) in patients (primary), or hospital staff or visitors (secondary), and the158 
number of deaths (secondary) and skin reactions (secondary).159 
5 
Assessment of risk of bias in included studies (assessment of quality of studies) 160 
Two review authors (LA, OB) independently assessed the risk of bias for each included study using 161 
the Risk of Bias Tool 1, as outlined on the Cochrane Handbook11. All disagreements were resolved by 162 
discussion or by referring to a third author (PG). The following domains were assessed: 163 
1. Random sequence generation164 
2. Allocation concealment165 
3. Blinding of participants and personnel166 
4. Blinding of outcome assessment167 
5. Incomplete outcome data168 
6. Selective outcome reporting169 































. Included 201 
studies were conducted in the last decade in the USA (n=3 studies15,18,20), Chile (n=2 studies17,21), 202 
Each potential source of bias was graded as low, high or unclear, and each judgement was supported 
by a quote from the relevant trial.  
Measurement of effect and data synthesis   
We used risk ratios or rate ratios for dichotomous outcomes – risk ratios for results reporting the 
number of patients with an event, and rate ratios for the results reporting the number of events 
only. We undertook meta-analyses only when meaningful (when ≥2 studies or comparisons reported 
the same outcome); anticipating considerable heterogeneity, we used a random effects model. We 
used Review Manger 5 to calculate the intervention effect. 
Assessment of heterogeneity and reporting biases  
We considered both clinical and methodological heterogeneity among included studies (i.e. 
differences between included studies in terms of population, intervention, comparison, outcomes, 
and study designs). We supplemented this assessment of clinical and methodological heterogeneity 
with information regarding statistical heterogeneity, assessed using the Chi² test (we considered a 
significance level of P < 0.10 to indicate statistically significant heterogeneity) in conjunction with the 
I² statistic (I² ≥ 75% indicates considerable heterogeneity)12. Because we included fewer than 10 
trials, we did not create a funnel plot.  
Dealing with missing data 
We contacted investigators or study sponsors to provide missing data. 
Subgroup and sensitivity analyses   
We planned to do a subgroup analysis by type of infection/patient and a sensitivity analysis by 
including versus excluding studies at high risk of bias, however, due to a low number of included 
studies, these analyses were not done.    
RESULTS 
We screened 638 titles and abstracts and assessed 16 full-text articles for inclusion. After excluding 6 
articles, we included 10 articles pertaining to 7 studies13-22. We also identified 5 relevant clinical trial 
registries (2 for studies already identified and included and 3 registries for studies that have not 
been published). Figure 1 shows PRISMA flow diagram of studies. Excluded full-text articles are 
presented in Appendix 2 with reasons for exclusion.  
Characteristics of included studies 
We included 7 controlled studies, which enrolled a total of 12,362 participants14,15,17,18,20-22
6 
France (n=1 study22), and Israel (n=1 study14). Three of the studies were set in adult ICUs15,18,20, one in 203 
paediatric ICU21, one in aged care facility22, one in acute care ward17, and one in long-term care for 204 
ventilator dependent patients14. Duration of the studies ranged from 7 to 16 months. 205 
Four of the included studies evaluated the effect of copper coating of commonly touched hard 206 
surfaces such as bed rails and tables, IV poles, door handles and taps on healthcare acquired 207 
infections17,18,21,22. Two studied copper-treated linens (bedding, patient gowns and towels)14,15 and 208 
one included both hard surfaces and linens20. All included studies reported the effect of copper on 209 
healthcare acquired infections in patients (i.e. primary outcome); none reported the effect on 210 
hospital staffs or visitors (i.e. secondary outcome). 211 
Risk of bias assessment (quality of studies) 212 
All of the 7 included studies were judged to be at high risk in two or more of the domains of bias. Of 213 
the 7 included studies, 5 were judged to be at high or unclear risk for selection bias (either random 214 
sequence generation or allocation concealment). All of included studies were judged to be at high or 215 
unclear risk in blinding of participants or personnel and conflict of interest (recorded as “other risk of 216 
bias”). All of included studies were judged to be at low risk in attrition bias (i.e. incomplete outcome 217 
data) and reporting bias (i.e. selective reporting).    218 
Effects of copper-treated surfaces  219 
Healthcare acquired infections (HAIs) 220 
All 7 included studies reported the effect of copper-treated surfaces on healthcare acquired 221 
infections. Overall, we found that copper-treated hard surfaces and/or bed linens and clothes 222 
reduced healthcare acquired infections by 27% (RR 0.73; 95% CI 0.57 to 0.94) (Figure 2).  223 
Copper-treated hard surfaces (4 studies) 224 
We identified 4 studies (2125 participants) that evaluated the effect of copper-treated hard surfaces 225 
on healthcare acquired infections17,18,21,22. There was no statistically significant reduction in HAIs 226 
among participants hospitalised in facilities with copper-treated surfaces compared to no copper (RR 227 
0.76, 95% CI 0.56 to 1.04; I²=38%).  228 
Copper-treated bed linens and clothes (2 studies) 229 
We identified 2 studies (276 participants) that evaluated the effect of copper-treated bed linens and 230 
clothes on HAIs14,15. We observed a statistically significant 25% relative reduction in HAIs among 231 
participants hospitalised in facilities with copper-treated bed linens and clothes compared to no 232 
copper (RR 0.75, 95% CI 0.58 to 0.98; I²=0%). 233 
Combined copper treated hard surfaces and bed linens and clothes (1 study) 234 
A single study of 9,961 participants evaluated the combined effect of both copper-treated hard 235 
surfaces and bed linens and clothes on HAIs20. A statistically significant 86% relative reduction in 236 
HAIs was observed among participants hospitalised in facilities with copper-treated surfaces 237 
compared to no copper (RR 0.14, 95% CI 0.0.03 to 0.61).  238 
Mortality 239 
Of the 7 included studies, 3 studies (included a total of 1,569 participants) reported the effect of 240 
copper-treated hard surfaces on mortality17,18,21. There was no statistically significant difference in 241 
mortality between participants hospitalised in facilities treated with copper compared to no copper 242 
(RR 1.06, 95% CI 0.83 to 1.36) (Figure 3).   243 
Skin reactions 244 
Of the 7 included studies, 2 studies reported data on skin reactions20,21. von Dessauer et al did not 245 














































group21. Sifri et al reported that 10 (of 4707) patients hospitalised in copper-treated rooms 
developed skin rashes (9 were evaluated by a dermatologist and attributed to alternative aetiology 
and 1 was discharged before evaluation)20.  
Heterogeneity in included studies 
We noted both clinical and methodological heterogeneity between included studies. For example, 
we found differences on how included studies defined and measured the primary outcome (i.e. 
HAIs). For instance, although 6 of the 7 included studies directly measured HAIs (i.e. infections not 
just colonisations), the RCT of 112 ventilator-dependent patients in a long-term care did not 
measure HAIs, instead, measured antibiotic initiation events as an indicator for HAIs14. Further, 4 of 
the 7 included studies determined HAIs following comparable definitions: 3 used the National 
Healthcare Safety Network (NHSN) definitions15,18,20 and 1 used National Surveillance System of the 
Ministry of Health of Chile (i.e. infections on and after third admission day)21; but the remaining 3 
studies did not clearly report how they define HAIs. Despite these differences, the quantified Q and 
I2 statistics did not identify substantial statistically heterogeneity - I² statistics of all metanalyses of 
all outcomes ranges between 0% to 44%, with all not significant P > 0.10). 
DISCUSSION 
We found seven controlled trials, which when combined suggest that copper surfacing or use in bed 
linen may have some effect on reducing healthcare acquired infections. The combined studies 
suggest a modest but potentially important effect. 
There are several limitations to our findings. First, many of the studies were poorly reported, 
preventing a clear appraisal of the methods. Second, even when reporting was clear, the research 
methods often involved flaws in study design which might introduce bias. Third, studies reported 
HAIs caused by different organisms, most of them bacterial (e.g. Pseudomonas spp., meticillin-
resistant Staphylococcus aureus, vancomycin-resistant enterococci) but also viral (e.g. norovirus and 
adenovirus), and different body system affected (e.g. respiratory, bloodstream, urinary). Fourth, 
although we did not identify substantial statistical heterogeneity (i.e. evaluated using Q test and I2 
statistics), observed clinical and methodological heterogeneity between studies limit our certainty in 
the effect estimates and poses interpretive challenges. Finally, the small total numbers of infections 
meant that the confidence intervals around effects were wide, indicating considerable uncertainty in 
the size of any effect. The poor quality of reporting and methods, and small sizes of the studies 
would both downgrade the overall quality of the evidence, rating it - in GRADE terms - as low-quality 
evidence but of a potentially clinically important effect. In addition to these problems, many of the 
investigator teams had a conflict of interest with companies involved in copper use. 
We report one difference between the protocol and the review: we had initially intended to include 
only studies of copper-plating of hard surfaces such as furniture. However, as several studies 
assessed the impact of copper-treating of textiles (clothing and/or bed linens) we broadened our 
inclusion criteria. This resulted in an inclusion of two clothing/linen-only studies14,15 and one study 
that assessed the impact of both furniture coating and Copper-impregnated textiles20. 









































Australia for Australia’s National Health and Medical Research Council (NHMRC) which found 2 of 
these studies18,21, and concluded that "With only two non-randomised trials, both with uncertain 
results, it is not possible to draw conclusions from this evidence." The three trials since then, plus 
two not identified in the 2017 review, have strengthened the body of evidence, but not sufficiently 
to be able to make strong recommendations. 
Finding effective and sustainable ways of reducing pathogen transmission is important for all 
epidemics but particularly urgent in the current SARS coronavirus 2 (SARS-CoV-2) pandemic23. 
Though the exact relative importance of different modes of transmission is currently unknown there 
appears to be three main avenues, namely direct aerosol, contact with fomites, and the most 
controversial, airborne transmission24. Reducing the incidence of infections will require addressing 
all modes of transmission. While social distancing is widely promoted it may not completely prevent 
fomite transmission if common objects such as door handles, stair banisters, table surfaces, utensils 
or taps are contaminated5. Therefore, our findings might be also relevant to the current COVID-19 
pandemic. 
Given the clinical and economic costs of healthcare acquired infections, the potential effect of 
copper coating appears important. We feel the current evidence is insufficient to make a positive 
recommendation. However, it would appear worthwhile and urgent to conduct larger scale publicly 
funded clinical trials with clearly defined outcomes into the impact of copper coating. If such studies 
were to be funded, it would also be important to collect additional data such as the separation of 
bacterial and viral infections and measuring outcomes for healthcare workers as well particularly for 
viral infections. 
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Figure 2: Forest plot of healthcare acquired infections in copper treated surfaces versus no copper. 
Abbreviation: ICUs, Intensive Care Units; PICUs, Paediatric ICUs.  






Figure 3: Forest plot of mortality in copper treated surfaces versus no copper.   



















Double-blind RCT, 11 
months 
614 adult ICU 
patients (60.4 yrs) 
Copper-treated surfaces 
Copper covering of bed rails, overbed tables, intravenous 
poles, and arms of the visitor's chair the nurses' call button, 
computer mouse, bezel of touchscreen monitor, palm rest of 
laptop were different depending on the hospitals) 
Regular ICU 
Incident Rate of HAI and/or MRSA or VRE 
colonization. HAIs were determined using 
NHSN definitions (i.e. infections on and 




Controlled trial, 13 
months 
440 adult ICU 
patients (51 yrs) 
Copper-treated surfaces  
C11000 copper alloy (99% copper) equivalent to 
approximately 80% of the areas most touched by patients 
(four bed rails, patient table 
and two IV poles)  
Regular ICU 







clinical trial, 12 months 
65 paediatric ICU 
(1 yr) 
Copper-treated surfaces  
Copper covering of bed rails, bed rail levers, intravenous 
poles, sink handles, and the nurses’ workstation 
Regular 
PICU 
Diagnosis of a HAI event associated with 
patient stay within the PICU or PIMCU. 
HAIs were determined by standard 
definitions used by the National 
Surveillance System of the Ministry of 
Health of Chile (i.e. infections on and after 




Controlled trial, 16 
months 
556 nursing home 
residents (85.4 
yrs) 
Copper-treated surfaces  
438 door handles, 322 m of handrails, and 10 grab-bars in 





Rates of infection during outbreak (5 cases 






cross-over, 7 months (2 
x 3 months, separated 




patients in a long-
term care hospital 
(69.8 vs 71.3 yrs) 
Copper-treated textiles  
Copper oxide–impregnated linen and hospital patients’ 
clothes and towels. 
Regular ICU 
Antibiotic treatment initiation events 
(ATIEs), fever days, days of antibiotic 
treatment, and antibiotic defined daily 
dose (DDD) per 1,000 hospitalization days 
(HDs). We used ATIEs as an indirect 






control trial, 11 months 
(2 x 5 months separated 
by 2 weeks of wash-out) 
1282 adult ICU 
patients (60 yrs) 
Copper-treated textiles 
Copper-oxide-treated linens (top sheets, fitted sheets, 
pillowcases, under pads, wash cloths, towels, and patient 
gowns) 
Regular ICU 
 HCAIs were determined using NHSN 
definitions (i.e. infections on and after 





study with a control 
group, 10 months 
9961 adult acute 
care patients 
(58.5 vs 60.5 yrs) 
Combined Copper treated textiles and surfaces 
16% copper oxide-impregnated composite countertops 
(sinks, vanities, desks, computer stations, soiled utility 
rooms, nurse workstations) and moulded surfaces (overbed 
tray tables, bedrails) and copper-impregnated woven linens 
(patient gowns, bedding, washcloths, towels, bath blankets, 
thermal blankets) 
Regular ICU 
Incidence Rate of hospital-onset infections 
(C difficile or MDRO). HAIs were 
determined using NHSN definitions (i.e. 
infections on and after third admission 
day) 
ICU – Intensive Care Unit/s; HAI -healthcare acquired infection/s; MRSA – methicillin-resistant Staphylococcus aureus; VRE - vancomycin-resistant Enterococcus; PICU – Paediatric Intensive 
Care Unit/s; PIMCU - intermediate paediatric care unit; HCAI - healthcare-associated infections; MDRO - multidrug resistant organisms; NHSN - National Healthcare Safety Network 
* This is as reported by the authors of included studies, however, we extracted only the outcomes that we proposed in the methods (e.g. if authors reported both colonization and HAIs, we 




DATABASE SEARCH STRINGS 
PubMed 
("Copper"[Mesh] OR Copper[tiab]) 
AND 
("Infections"[Mesh] OR "Equipment Contamination"[Mesh] OR "Infection Control"[Mesh] OR "Cross Infection"[Mesh] OR Infection[tiab] OR Infections[tiab] 
OR Colonization[tiab]) 
AND 
("Health Facilities"[Mesh] OR Hospital[tiab] OR Hospitals[tiab] OR “Healthcare facility”[tiab] OR “Healthcare facilities”[tiab] OR  “Intensive care”[tiab] OR 
“Intensive-care”[tiab] OR ICU[tiab] OR PICU[tiab] OR Ward[tiab] OR Wards[tiab]) 
AND 
(Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR "drug therapy"[sh] OR 
randomly[tiab] OR trial[tiab] OR groups[tiab] OR Control[tiab] OR Controlled[tiab] OR Comparing[tiab] OR Compared[tiab]) 
NOT  
(Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])) 
NOT 
(“Case Reports”[pt] OR Editorial[pt] OR Letter[pt] OR "Comment"[pt] OR Meta-Analysis[pt] OR “Observational Study”[pt] OR “Systematic Review”[pt] OR 
“Case Report”[ti] OR “Case series”[ti] OR Meta-Analysis[ti] OR “Meta Analysis”[ti] OR “Systematic Review”[ti]) 
Cochrane CENTRAL 
([mh Copper] OR Copper:ti,ab) 
AND 
([mh Infections] OR [mh "Equipment Contamination"] OR [mh "Infection Control"] OR [mh "Cross Infection"] OR Infection:ti,ab OR Infections:ti,ab OR 
Colonization:ti,ab) 
AND 
([mh "Health Facilities"] OR Hospital:ti,ab OR Hospitals:ti,ab OR "Healthcare facility":ti,ab OR "Healthcare facilities":ti,ab OR "Intensive care":ti,ab OR 
ICU:ti,ab OR PICU:ti,ab OR Ward:ti,ab OR Wards:ti,ab) 
Embase (via Elsevier) 
17 
('Copper'/exp OR Copper:ti,ab) 
AND 
('Infection'/exp OR 'medical device contamination'/exp OR 'Infection Control'/exp OR 'Cross Infection'/exp OR Infection:ti,ab OR Infections:ti,ab OR 
Colonization:ti,ab) 
AND 
('health care facility'/exp OR Hospital:ti,ab OR Hospitals:ti,ab OR "Healthcare facility":ti,ab OR "Healthcare facilities":ti,ab OR "Intensive care":ti,ab OR 
Intensive-care:ti,ab OR ICU:ti,ab OR PICU:ti,ab OR Ward:ti,ab OR Wards:ti,ab) 
AND 
(random* OR factorial OR crossover OR placebo OR blind OR blinded OR assign OR assigned OR allocate OR allocated OR 'crossover procedure'/exp OR 
'double-blind procedure'/exp OR 'randomized controlled trial'/exp OR 'single-blind procedure'/exp OR Control:ti,ab OR Controlled:ti,ab OR Comparing:ti,ab 
OR Compared:ti,ab) 
NOT  
('animal'/exp NOT ('animal'/exp AND 'human'/exp)) 
18 
APPENDIX 2 
Excluded studies: Details of the 6 full-text articles screened in full text but excluded from the review with reason for their ineligibility 
Author, Year Title Journal Reason for exclusion 
Butler 2016 Effect of copper-impregnated composite bed linens and patient gowns 
on healthcare-associated infection rates in six hospitals 




A randomized controlled trial of the effect of accelerated copper 
textiles on healthcare-associated infections and multidrug-resistant 
organisms: The “investigating microbial pathogen activity of copper 
textiles” (impact) study 
Open Forum Infectious 
Diseases 




The antimicrobial scrub contamination and transmission (ASCOT) trial: 
A three-arm, blinded, randomized controlled trial with crossover 
design to determine the efficacy of antimicrobial-impregnated scrubs 
in preventing healthcare provider contamination 
Infection Control and 
Hospital Epidemiology 




Superfici al rame e infezioni ospedaliere Assistenza Infermieristica 
e Ricerca 
No primary data 
Abbas 2019 Infection prevention: is copper the new gold? Journal of Hospital 
Infection 
No primary data 
Butler 2019 Reply to Abbas et al. “Infection prevention: Is copper the new gold?” Journal of Hospital 
Infection 
No primary data 
